SEC Form D · filed July 13, 2018
Carmell Therapeutics Corp
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (14)
Alex R. Duncan · Lexington, MAExecJay Venkatesan · Los Angeles, CAExecJames Connolly · Los Angeles, CAExec · DirectorJustin Fallon · Los Angeles, CADirectorEvan R. Kearns · Lexington, MADirectorMichael Meyers · Los Angeles, CADirectorChristian R. Cortis · Lexington, MAExecAndrew W. Dym · New York, NYExecDavid W. Schiff · New York, NYDirectorJoseph W. Schottland · New York, NYDirectorMax Lin · MENLO PARK, CAExec · DirectorJim Momtazee · MENLO PARK, CAExecMark Bisso · HOUSTON, TXExecAndrew J. Duffy · New York, NYDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗